Skip to content
10-Q

Quarterly Report

Raphael Pharmaceutical Inc. RAPH

0001213900-24-098456

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 11, 2024 18.7M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $40K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $230K
Current Liabilities Q3 2024 · Sep 30, 2024 $667K
Current Liabilities Q3 2024 · Dec 31, 2023 $72K
Current Assets Q3 2024 · Sep 30, 2024 $49K
Current Assets Q3 2024 · Dec 31, 2023 $337K
Total Assets Q3 2024 · Sep 30, 2024 $51K
Total Assets Q3 2024 · Dec 31, 2023 $339K
Net Income Q3 2024 · Jun 30, 2024 −$798K
Net Income Q3 2024 · Sep 30, 2023 −$725K
Net Income Q3 2024 · Sep 30, 2023 −$1.41M
Net Income Q3 2024 · Jun 30, 2023 −$681K
Stock Issued Q3 2024 · May 31, 2024 40K sh
Shares Diluted Q3 2024 · Sep 30, 2023 16.44M sh
Shares Diluted Q3 2024 · Sep 30, 2023 16.17M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$1.12M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$75K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$61K
Stockholders Equity Q3 2024 · Dec 31, 2022 $106K
Eps Diluted Q3 2024 · Sep 30, 2023 $0.04
Eps Diluted Q3 2024 · Sep 30, 2023 $0.09
Eps Basic Q3 2024 · Sep 30, 2023 $0.04
Eps Basic Q3 2024 · Sep 30, 2023 $0.09
Sga Expense Q3 2024 · Sep 30, 2023 $219K
Sga Expense Q3 2024 · Sep 30, 2023 $489K
Rd Expense Q3 2024 · Sep 30, 2023 $510K
Rd Expense Q3 2024 · Sep 30, 2023 $917K
Operating Income Q3 2024 · Sep 30, 2023 −$729K
Operating Income Q3 2024 · Sep 30, 2023 −$1.41M